$119 Million is the total value of Belmont Global Advisors, Inc.'s 111 reported holdings in Q1 2014. The portfolio turnover from Q4 2013 to Q1 2014 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SGYPQ | SYNERGY PHARMACEUTICALS DEL | $1,327,000 | -5.7% | 250,000 | 0.0% | 1.12% | -1.8% | |
| WGP | WESTERN GAS EQUITY PARTNERS | $1,301,000 | +24.3% | 26,500 | 0.0% | 1.09% | +29.3% | |
| TYC | TYCO INTERNATIONAL LTD | $933,000 | +3.3% | 22,000 | 0.0% | 0.78% | +7.5% | |
| SBAC | SBA COMMUNICATIONS CORP | $573,000 | +1.2% | 6,300 | 0.0% | 0.48% | +5.5% | |
| OIH | MARKET VECTORS ETF TRoil svcs etf | $564,000 | +4.8% | 11,200 | 0.0% | 0.47% | +9.2% | |
| GOOGL | GOOGLE INCcl a | $496,000 | -0.6% | 445 | 0.0% | 0.42% | +3.5% | |
| DMLP | DORCHESTER MINERALS LP | $393,000 | +0.8% | 15,000 | 0.0% | 0.33% | +4.8% | |
| PEJ | POWERSHARES ETF TRUSTdyn lsr & ent | $357,000 | +0.3% | 10,450 | 0.0% | 0.30% | +4.5% | |
| HCRSQ | HI-CRUSH PARTNERS LP | $323,000 | +6.2% | 8,000 | 0.0% | 0.27% | +10.6% | |
| EFC | ELLINGTON FINANCIAL LLC | $299,000 | +4.9% | 12,550 | 0.0% | 0.25% | +9.1% | |
| OAK | OAKTREE CAP GROUP LLCunit cl a | $291,000 | -1.0% | 5,000 | 0.0% | 0.24% | +3.4% | |
| PM | PHILIP MORRIS INTL INC | $270,000 | -6.2% | 3,300 | 0.0% | 0.23% | -2.6% | |
| DFE | WISDOMTREE TReurope smcp dv | $263,000 | +8.2% | 4,200 | 0.0% | 0.22% | +12.8% | |
| FLS | FLOWSERVE CORP | $215,000 | -0.9% | 2,750 | 0.0% | 0.18% | +3.4% | |
| CBZ | CBIZ INC | $137,000 | 0.0% | 15,000 | 0.0% | 0.12% | +3.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-05-13
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ZIOPHARM ONCOLOGY INC | 12 | Q3 2016 | 21.1% |
| INTREXON CORP | 12 | Q3 2016 | 13.1% |
| FACEBOOK INC | 12 | Q3 2016 | 3.4% |
| PIMCO DYNAMIC INCOME FD | 11 | Q3 2016 | 2.2% |
| SYNERGY PHARMACEUTICALS DEL | 11 | Q3 2016 | 1.4% |
| CBIZ INC | 11 | Q2 2016 | 0.2% |
| ZIOPHARM ONCOLOGY INC | 10 | Q3 2016 | 14.8% |
| LA JOLLA PHARMACEUTICAL CO | 10 | Q2 2016 | 3.4% |
| APPLE INC | 10 | Q3 2016 | 3.2% |
| MEDGENICS INC | 10 | Q2 2016 | 2.1% |
View Belmont Global Advisors, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2016-11-14 |
| 13F-HR | 2016-08-15 |
| 13F-HR | 2016-05-16 |
| 13F-HR | 2016-02-16 |
| 13F-HR | 2015-11-16 |
| 13F-HR | 2015-08-14 |
| 13F-HR | 2015-05-15 |
| 13F-HR | 2015-02-17 |
| 13F-HR | 2014-11-14 |
| 13F-HR | 2014-08-14 |
View Belmont Global Advisors, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.